Nordic Life Science 1
WuXi AppTec ADVERTORIAL “Ensuring that all stakeh
olders are aligned, communicating, and aware of their specific roles throughout the manufacturing and distribution timeline is critical to avoiding delays and improving performance.” with a CRDMO that offers the full pipeline as an end-to-end solution, both to clients who wish to do the entire journey from start to finish with WuXi AppTec, and for those who only need support at critical decision points working towards specific milestones. “We support the entire drug development journey and provide support at every step,” Thomas Meins says. “We are passionate about empowering all types of innovators, from academia and startups to research institutes and big pharmas, to make use of every exit and entry points. Together, we tailor programmes to guide clients step by step toward key decision point.” “With 25 years of experience, we understand the many paths a project can take. No matter where a programme stands, we can help clients navigate the next steps to bring therapies to patients. Everybody who partners with us profits from this, whether they use selected elements or our entire platform,” he adds. Thomas Meins, who has kept his startup mindset, speaks fondly about WuXi AppTec as an active participant in local life science ecosystems and as an enabler of bringing big ideas from small companies forward. He began his career at a large pharma company and then moved “We support the entire drug development journey and provide support at every step.” over to Crelux at a time when the company was still fresh on its feet in the startup phase – years before the subsidiary became a part of WuXi AppTec in 2016. He emphasizes the deep understanding of the startup journey that prevails at the company and points out that some of the clients who opt to bring WuXi AppTec in from the very beginning are so early-stage that they don’t even have a website yet. “If you are in an early phase, you often don't have that much understanding of what it takes to reach Investigational New Drug and to go into development. We have a clear consulting function, and it goes beyond scientific consultations. You also need investments. Here, we can guide you on what to prepare, which data you need, and how to present your data-set so that the investors take you seriously. We aid in building an ecosystem around the startup, which is helpful because the drug discovery development process is very, very complicated,” Thomas Meins says. “We sometimes say that we’re a navigation system. There are a hundred different routes you can take to reach your destination, and we can help in showing you the best possible routes,” he concludes. Please visit: wuxiapptec.comCMYK: 99.90.0.0 PANTONE 2736C CMYK: 80.22.7.0 PANTONE 299C PHOTO CRELUX, A WUXI APPTEC COMPANY PHOTO CRELUX, A WUXI APPTEC COMPANY